CoChat

Epidemiology of isotretinoin exposure during pregnancy

Dai, Wanju S., LaBraico, James M., Stern, Robert S. · 1992 · Journal of the American Academy of Dermatology

The DOI matches its Crossref record; 8 of the 8 references it cites were found in a registry or an index.

Abstract

Background Exposure to isotretinoin during pregnancy is associated with a high risk of major fetal malformations. Objective Our purpose was to determine the reasons for and outcomes of in utero isotretinoin exposure. Methods On the basis of 433 spontaneous reports, we describe the likely reasons these exposures occurred and the outcomes of these pregnancies. In our analysis of the outcomes of pregnancy, we separately consider the pregnancies known to us before their outcomes were determined as prospective cases. Results Timing of conception in relation to initiation of therapy with isotretinoin was known for 396 women. Of these, 130 patients (33%) were already pregnant when they started isotretinoin. An additional 65 patients (16%) became pregnant in the first 3 weeks of isotretinoin use. Pregnancy outcomes were known on 409 pregnancies. Among these, 222 (54%) ended in elective abortion and 29 (7%) in spontaneous or missed abortion. Of 151 births, 72 (48%) were normal, 71 (47%) had congenital malformations, and 8 (5%) had abnormalities other than malformations. Of 94 prospectively ascertained pregnancies that ended in births, 28% had congenital malformations (95% confidence interval 19% to 37%). Exposure to isotretinoin during any time and for as little as one capsule within the first trimester have been associated with congenital malformations. Conclusion The high proportion of exposures in already or recently pregnant women illustrates the importance of obtaining a negative…

Overview

Integrity signals

Registry

Crossref · 10.1016/0190-9622(92)70088-w

Cites

8 of 8 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Verification

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Citations

Cites

Show all 8 references

Research works printed but not linked: 4

  1. 1983, Adverse effects with isotretinoin, FDA Drug Bull, 13, 2123
  2. 1984, Update on birth defects with isotretinoin, FDA Drug Bull, 14, 15
  3. Lammer, 1988, Unusual high risk for adverse outcomes of pregnancy following fetal isotretinoin exposure [Abstract], Am J Hum Genet, 43, A58
  4. Mitchell, 1990, Accutane exposure in pregnancy—a novel survey design [Abstract], Teratology, 41, 578

Cited by

See all 134

Metadata

Authors
Dai, W. S., LaBraico, J. M., & Stern, R. S.
Affiliations
Harvard University (US)
Corresponding author
Dai, Wanju S.
Venue
Journal of the American Academy of Dermatology
Publisher
Elsevier BV
Published
1992-04
Volume
26
Issue
4
Pages
599-606
ISSN
0190-9622 (ISSN-L)
OpenAlex
W2107996839
Cited by
133
References
8
Citations by year
2026: 2 · 2025: 3 · 2024: 3 · 2023: 4 · 2022: 5 · 2021: 3 · 2020: 4 · 2019: 3 · 2018: 3 · 2017: 6 · 2016: 2 · 2015: 4 · 2014: 4 · 2013: 2 · 2012: 10
FWCI
6.25
Type
journal article
Language
en
Open access
closed
Licence
  • www.elsevier.com/tdm/userlicense/1.0/ (tdm)
  • www.elsevier.com/legal/tdmrep-license (tdm)
Locations
  • Journal of the American Academy of Dermatology (publishedVersion)
  • PubMed (publishedVersion)
Topics
  • Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Pregnancy and Medication Impact
  • Health Sciences › Medicine › Dermatology › Acne and Rosacea Treatments and Effects
  • Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Reproductive Health and Contraception
Keywords
isotretinoin, pregnancy, teratogenicity, congenital malformations, fetal malformations, conception timing, pregnancy testing, contraception, acne treatment, miscarriage, missed abortion
MeSH terms
Abnormalities, Drug-Induced, Abortion, Spontaneous, Abortion, Induced, Adolescent, Adult, Contraception Behavior, Female, Humans, Pregnancy, Pregnancy Outcome, Prospective Studies, Retrospective Studies, Isotretinoin

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Epidemiology of isotretinoin exposure during pregnancy. https://app.cochat.ai/papers/10.1016/0190-9622(92)70088-w
The paper
Dai, W. S., LaBraico, J. M., & Stern, R. S. (1992). Epidemiology of isotretinoin exposure during pregnancy. Journal of the American Academy of Dermatology. https://doi.org/10.1016/0190-9622(92)70088-w

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.